TickerGuard
Buy Day today: Poor (44) Weak market breadth · no major macro event
MIST

Milestone Pharmaceuticals Inc

Healthcare · Biotechnology

0.6552$ -1.1% vs. previous close Closing price · As of: Nov 12, 2026

Ownership

Ownership Structure

Who owns Milestone Pharmaceuticals Inc (MIST)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 85.3% of the shares are freely tradable; institutional investors hold 41.9%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 41.9%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 0.7%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 85.3%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 15.9%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 125Mio.

Largest Shareholders

Institutions

Institutions MIST
Name Stake (%) Shares Change (%) Date
Pavaki Capital Management LLC 7.50 9,337,848 +3.0 09/30/2026
RTW INVESTMENTS, LLC 6.29 7,833,336 +23.7 06/30/2026
Propel Bio Management LLC 5.97 7,429,590 +80.4 06/30/2026
Point72 Asset Management, L.P. 4.35 5,411,138 +398.4 06/30/2026
Simplify Asset Management Inc. 2.69 3,349,379 +0.0 09/30/2026
Millennium Management LLC 2.52 3,142,219 +103.5 06/30/2026
Kalehua Capital Management LLC 2.04 2,538,474 +0.0 06/30/2026
Two Sigma Investments LLC 1.64 2,040,015 -12.0 06/30/2026
Marshall Wace Asset Management Ltd 1.44 1,797,695 -7.6 06/30/2026

Funds

Funds MIST
Name Stake (%) Shares Change (%) Date
Simplify Propel Opportunities ETF 2.69 3,349,379 +0.0 10/29/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: November 12, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?